Summary
Provides WHO guidance on the governance of large multi-modal generative AI models used in clinical care, public health, research, and drug development, identifying risks and recommendations across design, development, procurement, deployment, and oversight.
Healthcare Implications
Governments, health systems, and developers should define intended uses, document evidence and limitations, engage affected stakeholders, protect privacy, test safety and bias, preserve human accountability, and monitor model performance after deployment, especially for patient-facing and clinical applications.